Back
DBS Group Holdings Ltd. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
55
DBSDF
DBS Group Holdings Ltd.
Last Price:
$43.15
Seasonality Move:
2.57%
Sell
36
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.91
Seasonality Move:
-18.07%
Buy
55
DBS Group Holdings Ltd. (DBSDF)
is a Buy
Is DBS Group Holdings Ltd. a Buy, Sell or Hold?
-
The current DBS Group Holdings Ltd. [DBSDF] share price is $42.30. The Score for DBSDF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
DBSDF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $12.18. The Score for INKT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DBSDF Stock Price Chart
What is DBS Group Holdings Ltd.'s stock price today?
-
The DBS Group Holdings Ltd. share price today is $42.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBSDF is experiencing slight selling pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $12.18Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
DBSDF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 50.18 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.6 - 42.96) | Buy |
| Bollinger Bands (100): | (39.04 - 42.9) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 49.45 | Sell |
| Chaikin Money Flow: | -21857 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.95) | Buy |
| Bollinger Bands (100): | (12.31 - 15.53) | Sell |
DBSDF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.56 | Sell |
| 20-day SMA: | 42.29 | Buy |
| 50-day SMA: | 42.1 | Buy |
| 200-day SMA: | 37.58 | Buy |
| 8-day EMA: | 42.54 | Sell |
| 20-day EMA: | 42.36 | Sell |
| 50-day EMA: | 41.87 | Buy |
| 200-day EMA: | 38.24 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.34 | Sell |
| 20-day SMA: | 11.54 | Buy |
| 50-day SMA: | 13.05 | Sell |
| 200-day SMA: | 11.82 | Buy |
| 8-day EMA: | 12.2 | Sell |
| 20-day EMA: | 12.1 | Buy |
| 50-day EMA: | 12.75 | Sell |
| 200-day EMA: | 12.24 | Sell |
DBS Group Holdings Ltd. Earnings Growth & DBSDF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
DBS Group Holdings Ltd. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||